<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lekakis, J.</style></author><author><style face="normal" font="default" size="100%">Dimopoulos, M.A.</style></author><author><style face="normal" font="default" size="100%">Prassopoulos, V.</style></author><author><style face="normal" font="default" size="100%">Mavrikakis, M.</style></author><author><style face="normal" font="default" size="100%">Gerali, S.</style></author><author><style face="normal" font="default" size="100%">Sifakis, N.</style></author><author><style face="normal" font="default" size="100%">Athanassoulis, T.</style></author><author><style face="normal" font="default" size="100%">Stamatelopoulos, S.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Myocardial adrenergic denervation in patients with primary (AL) amyloidosis</style></title><secondary-title><style face="normal" font="default" size="100%">Amyloid</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">AL amyloidosis</style></keyword><keyword><style  face="normal" font="default" size="100%">MIBG</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2003</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2003</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-0042703599&amp;partnerID=40&amp;md5=2e0a06ebf64f75259619816528aa139e</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">117 - 120</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">Three patients, 2 women and 1 man, with primary (AL) amyloidosis without congestive heart failure are described; all 3 patients presented reduced I-123 metaiodobenzylguanidine(MIBG) myocardial uptake suggesting marked cardiac sympathetic denervation. This is the first time myocardial adrenergic denervation is described in patients with AL amyloidosis without evidence of congestive heart failure; the observed denervation could be implicated in the pathogenesis of cardiac conduction disturbances which are common in this disease.</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><notes><style face="normal" font="default" size="100%">Cited By :4Export Date: 21 February 2017</style></notes></record></records></xml>